¿Es la diálisis peritoneal la mejor opción de tratamiento durante la pandemia por COVID-19?

Descargas

La descarga de datos todavía no está disponible.

Referencias

World Health Organization (WHO). Coronavirus disease (COVID-19) Situation Report - 103. Geneva: WHO; 2020 [citado Jul 22 2020]. Disponible en: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200722-covid-19-sitrep184.pdf?sfvrsn=7680210a_2.

Perú. Ministerio de Salud (Minsa). Sala Situacional COVID - 19 Perú. Lima Minsa; 2020 [citado Jul 22 2020]. Disponible en:https://covid19.minsa.gob.pe/sala_situacional.asp.

Guan W, Ni Z, Hu Y, Liang W, OU C, He J, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382:1708-20. http://dx.doi.org/10.1056/NEJMoa2002032.

Richardson S, Hirsch JS, Narasimhan M, Crawford J, MacGinn T, Davidson KW, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020;323(20):2052-9. http://dx.doi.org/10.1001/jama.2020.6775.

Li X, Xu S, Yu M, Wnag K, Tao Y, Zhou Y, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146;(1):110-8. http://dx.doi.org/10.1016/j.jaci.2020.04.006.

Henry BM, Lippi G. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID?19) infection. Int Urol Nephrol. 2020;52(6):1193-4. https://doi.org/10.1007/s11255-020-02451-9.

Wang K, Zhang Z, Yu M, Tao Y, Xie M. 15-day mortality and associated risk factors for hospitalized patients with COVID-19 in Wuhan, China: an ambispective observational cohort study. Intensive Care Med. 2020;46(7):1472-4. https://doi.org/10.1007/s00134-020-06047-w.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62. http://dx.doi.org/10.1016/S0140-6736(20)30566-3.

Lukowsky LR, Mehrotra R, Kheifets L, Arah OA, Nissenson AR, Kalantar-Zadeh K. Comparing mortality of peritoneal and hemodialysis patients in the first 2 years of dialysis therapy: a marginal structural model analysis. Clin J Am Soc Nephrol. 2013;8(4):619-28. http://dx.doi.org/10.2215/CJN.04810512.

Ma Y, Diao B, Lv X, Zhu J, Liang W, Liu L, et al. COVID-19 in hemodialysis (HD) patients: report from one HD center in Wuhan, China. medRxiv. https://doi.org/10.1101/2020.02.24.20027201.

El Shamy O, Sharma S, Winston J, Uribarri J. Peritoneal Dialysis During the Coronavirus 2019 (COVID-19) Pandemic: Acute Inpatient and Maintenance Outpatient Experiences. Kidney Med. 2020. https://doi.org/10.1016/j.xkme.2020.04.001.

El Shamy O, Tran H, Sharma S, Ronco C, Narayanan M, Uribarri J. Telenephrology with Remote Peritoneal Dialysis Monitoring during Coronavirus Disease 19. Am J Nephrol. 2020;51:480-2. http://dx.doi.org/10.1159/000508023.

Sourial MY, Sourial MH, Dalsan R, Graham J, Ross M, Chen W, et al. Urgent Peritoneal Dialysis in Patients With COVID19 and Acute Kidney Injury: A Single-Center Experience in a Time of Crisis in the United States. Am J Kidney Dis. 2020. https://doi.org/10.1053/j.ajkd.2020.06.001.

El Shamy O, Patel N, Abdelbaset MH, Chenet L, Tokita J, Lookstein R, et al. Acute Start Peritoneal Dialysis during the COVID-19 Pandemic: Outcomes and Experiences. JASN. 2020;31(6):1-10. https://doi.org/10.1681/ASN.2020050599.

Srivatana V, Aggarwal V, Finkelstein FO, Naljayan M, Crabtree JH, Perl J. Peritoneal Dialysis for Acute Kidney Injury Treatment in the United States: Brought to you by the COVID-19 Pandemic. Kidney360. 2020,1(5):410-5. http://dx.doi.org/10.34067/KID.0002152020.

Publicado
2020-06-30
Cómo citar
1.
Vizcarra Vizcarra CA. ¿Es la diálisis peritoneal la mejor opción de tratamiento durante la pandemia por COVID-19?. Rev. Colomb. Nefrol. [Internet]. 30 de junio de 2020 [citado 26 de noviembre de 2020];7(Supl.2). Disponible en: https://revistanefrologia.org/index.php/rcn/article/view/456